TY - JOUR
T1 - Looking for the “little things”
T2 - A multi-disciplinary approach to medicines monitoring for older people using the ADRe resource
AU - Hughes, David
AU - Jordan, Meirion
AU - Logan, Patricia A.
AU - Willson, Alan
AU - Snelgrove, Sherrill
AU - Storey, Melanie
AU - Vaismoradi, Mojtaba
AU - Jordan, Sue
N1 - Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/10/19
Y1 - 2020/10/19
N2 - Advances in medicines have increased the effectiveness of treatments and the social and cultural authority of doctors. However, as prescribing has become the dominant modality of treatment, the “pharmaceuticalization” of medical practice has often resulted in treatment “at a distance”, with doctors having limited contact with patients. Older and poorer people, who are socially distanced from medical prescribers, suffer more adverse drug reactions (ADRs) than the general population. A team approach to checking patients systematically for ADRs, as detailed in manufacturers’ literature, can minimise medication errors, but regular review is rare. This paper explains the benefits of medicines monitoring to protect older patients from iatrogenic harm, such as over-sedation, falls, or drug-induced Parkinsonism. We show how multidisciplinary initiatives to optimise prescribing can be supported by using a recognised resource—the adverse drug reaction profile (ADRe). The profile identifies and documents patients’ signs and symptoms of putative ADRs. Better monitoring allows professionals to adjust prescribing and respond to identified problems with agility. Implementation of systematic monitoring will require changes to the regulatory regime and better inter-professional cooperation. Providing carers, nurses and pharmacists with a structured system to monitor patients would democratise relevant medical knowledge and help address ageism and the socio-economic health divide.
AB - Advances in medicines have increased the effectiveness of treatments and the social and cultural authority of doctors. However, as prescribing has become the dominant modality of treatment, the “pharmaceuticalization” of medical practice has often resulted in treatment “at a distance”, with doctors having limited contact with patients. Older and poorer people, who are socially distanced from medical prescribers, suffer more adverse drug reactions (ADRs) than the general population. A team approach to checking patients systematically for ADRs, as detailed in manufacturers’ literature, can minimise medication errors, but regular review is rare. This paper explains the benefits of medicines monitoring to protect older patients from iatrogenic harm, such as over-sedation, falls, or drug-induced Parkinsonism. We show how multidisciplinary initiatives to optimise prescribing can be supported by using a recognised resource—the adverse drug reaction profile (ADRe). The profile identifies and documents patients’ signs and symptoms of putative ADRs. Better monitoring allows professionals to adjust prescribing and respond to identified problems with agility. Implementation of systematic monitoring will require changes to the regulatory regime and better inter-professional cooperation. Providing carers, nurses and pharmacists with a structured system to monitor patients would democratise relevant medical knowledge and help address ageism and the socio-economic health divide.
KW - Adverse drug reactions
KW - Community care
KW - Long-term care
KW - Medicine management
KW - Nursing
KW - Older people care
KW - Patient safety
UR - http://www.scopus.com/inward/record.url?scp=85093669819&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85093669819&partnerID=8YFLogxK
U2 - 10.3390/geriatrics5040079
DO - 10.3390/geriatrics5040079
M3 - Article
C2 - 33086499
AN - SCOPUS:85093669819
SN - 2308-3417
VL - 5
SP - 1
EP - 13
JO - Geriatrics (Switzerland)
JF - Geriatrics (Switzerland)
IS - 4
M1 - 79
ER -